Publikationen von Christoph W. Turck
Alle Typen
Zeitschriftenartikel (167)
2017
Zeitschriftenartikel
1047, S. 131 - 140 (2017)
MALDI imaging mass spectrometry Analysis - A new approach for protein mapping in multiple sclerosis brain lesions. JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
Zeitschriftenartikel
151, S. 97 - 105 (2017)
Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients. JOURNAL OF PROTEOMICS
Zeitschriftenartikel
7, e1078 (2017)
Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systems. TRANSLATIONAL PSYCHIATRY
Zeitschriftenartikel
10, 272 (2017)
Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response. FRONTIERS IN MOLECULAR NEUROSCIENCE
Zeitschriftenartikel
7, 15788 (2017)
Ketamine's antidepressant effect is mediated by energy metabolism and antioxidant defense system. SCIENTIFIC REPORTS 2016
Zeitschriftenartikel
6, 35317 (2016)
Purine and pyrimidine metabolism: Convergent evidence on chronic antidepressant treatment response in mice and humans. SCIENTIFIC REPORTS
Zeitschriftenartikel
214 (2), S. 181 - 195 (2016)
Different cAMP sources are critically involved in G protein-coupled receptor CRHR1 signaling. JOURNAL OF CELL BIOLOGY
Zeitschriftenartikel
41 (7), S. 1751 - 1758 (2016)
Selective Mitochondrial Targeting Exerts Anxiolytic Effects In Vivo. NEUROPSYCHOPHARMACOLOGY
Zeitschriftenartikel
76, S. 74 - 83 (2016)
Fluoxetine treatment prevents the inflammatory response in a mouse model of posttraumatic stress disorder. JOURNAL OF PSYCHIATRIC RESEARCH
Zeitschriftenartikel
10, 52 (2016)
Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes. FRONTIERS IN CELLULAR NEUROSCIENCE
Zeitschriftenartikel
21 (2), S. 277 - 289 (2016)
FKBP51 inhibits GSK3 beta and augments the effects of distinct psychotropic medications. MOLECULAR PSYCHIATRY
Zeitschriftenartikel
2 (1), S. 46 - 59 (2016)
Fluoxetine Treatment Rescues Energy Metabolism Pathway Alterations in a Posttraumatic Stress Disorder Mouse Model. Molecular neuropsychiatry
Zeitschriftenartikel
26 (7), S. 1110 - 8 (2016)
Peripheral fibroblast metabolic pathway alterations in juvenile rhesus monkeys undergoing long-term fluoxetine administration. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology
Zeitschriftenartikel
10 (12), S. 1269 - 1272 (2016)
Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. Proteomics. Clinical applications
Zeitschriftenartikel
10 (12), S. 1269 - 1272 (2016)
Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family. SI 2015
Zeitschriftenartikel
9 (9-10 SI), S. 817 - 831 (2015)
The protein interactome of collapsin response mediator protein-2 (CRMP2/DPYSL2) reveals novel partner proteins in brain tissue. PROTEOMICS CLINICAL APPLICATIONS
Zeitschriftenartikel
20 (9), S. 1108 - 1119 (2015)
Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. MOLECULAR PSYCHIATRY
Zeitschriftenartikel
9, 180 (2015)
MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia. FRONTIERS IN CELLULAR NEUROSCIENCE
Zeitschriftenartikel
40 (5), S. 1222 - 1233 (2015)
Homer1/mGluR5 Activity Moderates Vulnerability to Chronic Social Stress. NEUROPSYCHOPHARMACOLOGY
Zeitschriftenartikel
18 (2), S. 239 - 251 (2015)
Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition. NATURE NEUROSCIENCE